Press Releases
Media Contact:
Erin Hill
ehill@iivs.org
301-947-1281
IIVS, RIFM and Shiseido Partner to Transfer Non-animal Photosafety Tests
July 14, 2020The Institute for In Vitro Sciences (IIVS) has entered into an agreement with Shiseido and the Research Institute for Fragrance Materials (RIFM) to support the technology transfer of non-animal tests for photosafety testing. The program aims to build upon IIVS’ current photosafety tiered testing program, which addresses photoirritation, through the development of additional testing strategies to...
IIVS’ Outreach Program for Non-animal Test Methods Supported by Chinese Cosmetic Company
June 22, 2020June 23, 2020, Gaithersburg, MD - US based non-profit Institute for In Vitro Sciences Inc. (IIVS) has received its first funding from a Chinese owned and operated beauty tech company, Shenzhen Basixing Technology Co., Ltd. The occasion is significant as it demonstrates the growing desire for non-animal test methods in China and the importance of the IIVS program to help implement ...
IIVS Receives Support for Non-Animal Testing From RIFM
September 9, 2019September 10, 2019, Gaithersburg, MD – The Institute for In Vitro Sciences, Inc. (IIVS) is excited to announce that it has received a grant from the Research Institute for Fragrance Materials (RIFM) to support its mission to promote non-animal methods. The grant will be used to purchase equipment that will enable IIVS to expand capabilities and offer several non-animal tests in ...
PETA Science Group and Tobacco Companies Donate to Save Animals
August 28, 2019Donated Equipment Will Help to Replace Animals in Respiratory Toxicity Testing
Gaithersburg, MD — The PETA International Science Consortium Ltd., Imperial Brands PLC, Altria Client Services (ALCS), British American Tobacco PLC, and Philip Morris International Inc have joined together to donate equipment that can help to replace the use of animals in respiratory testing...IIVS and Partners Win Contract from the European Commission to Develop Training for Non-animal Testing Methods
July 16, 2019July 16, 2019, Gaithersburg, MD – The Institute for In Vitro Sciences (IIVS) is pleased to announce it is part of a winning consortium, headed by SYRCLE (the Systematic Review Centre for Laboratory animal Experimentation), to develop interactive eLearning training modules. The application of the Replacement, Reduction and Refinement of animal testing, commonly known as “The ...
European Partnership Supports IIVS Training of Chinese Scientists in Non-animal Tests
May 9, 2019Gaithersburg, MD – May 8, 2019 – The Institute for In Vitro Sciences, Inc. (IIVS) has received a grant from the European Partnership for Alternative Approaches to Animal Testing (EPAA) to support its annual ...
China’s Acceptance of Certain Non-Animal Testing Methods for the Regulation of Cosmetics
April 3, 2019Gaithersburg, MD – April 3, 2019 – The Institute for In Vitro Sciences (IIVS) applauds China’s National Medical Products Administration (NMPA) for their acceptance of certain non-animal (alternative) test methods for the regulation of cosmetics. In a notice issued on March 22, the NMPA drafted acceptance of nine test methods including:
IIVS Appointed to China’s Alternatives Working Group for Cosmetics
October 9, 2018Gaithersburg, MD – October 9, 2018 – U.S. based Institute for In Vitro Sciences (IIVS) has been invited by China’s National Institute for Food and Drug Control (NIFDC) to join their working group on alternatives for cosmetics. The newly established group was announced by the NIFDC during their 2nd International ...
IIVS Collaborates with BASF and Givaudan to Validate a Non-animal Test for Regulatory Submissions
August 28, 2018GAITHERSBURG, MD –August 28– The Institute for In Vitro Sciences (IIVS), with an established track record in the validation of alternatives to animal testing, is teaming up with BASF and Givaudan to validate an improved skin sensitization reactivity method to address the needs of ...
IIVS Names Frank Gerberick as Chief Scientific Advisor
March 1, 2018GAITHERSBURG, MD – March 1, 2018 – The Institute for In Vitro Sciences, Inc. (IIVS) announced that it has appointed Frank Gerberick, PhD as its Chief Scientific Advisor. With his expertise and knowledge of technological advances and industry trends, Dr. Gerberick will advise the organization’s governing body on scientific matters and make recommendations on future directions...